Kidney Function Tests Market Size, Share & Trends Analysis Report 2021 - 2028

 Kidney Function Tests Industry Overview

The global kidney function tests market size was valued at USD 777.06 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.2% from 2021 to 2028. Factors, such as investments by market players, increasing R&D activities, high prevalence of kidney diseases, and rising government initiatives, are expected to significantly drive market growth. Kidney function tests are simple laboratory tests used for investigating and evaluating functions of the kidney. Increased risk of Chronic Kidney Disease (CKD) and Acute Kidney Injury (AKI) due to the rising prevalence of diabetes and hypertension has drastically upsurged the demand for these products. The outbreak of coronavirus has further fueled the product demand.

According to the study published by the National Kidney Foundation, people hospitalized due to Covid-19 are at significant risk of developing AKI. The study stated that Covid-19 patients were twice as likely to develop AKI as compared to non-Covid-19 patients. Health authorities recommended that Covid-19 patients who had an AKI should be tested regularly as their risk of developing CKD is higher than others. These factors will propel the kidney function tests market growth over the forecast period.

Gather more insights about the market drivers, restrains and growth of the Global Kidney Function Tests market

Rising R&D initiatives for the development of novel products are expected to significantly boost market growth during the forecast period. For instance, in January 2020, Germany-based SphingoTec GmbH launched its IB10 sphingotest penKid, a Point-of-Care (PoC) test for Proenkephalin (penKid). This biomarker enables real-time evaluation of kidney function with a normal blood test. In addition, growing investments in the field of kidney function testing are further expected to fuel the market growth. In January 2020, Sweden-based Elypta AB raised a seed round worth USD 7.0 million to develop the first urine test for kidney cancer.

Chronic kidney disease has become a global public health problem having a high economic cost associated with it. According to the National Institutes of Health (NIH), the global prevalence of CKD is around 14.0%. Also, the prevalence of CKD risk factors, such as diabetes, hypertension, and obesity, is on the rise owing to lifestyle changes. This has led to an increased demand for mandatory screening tests in patients with hypertension and diabetes for CKD, thus creating a high product demand. As per the data published by the International Diabetes Federation, in 2019, around 463.0 million adults had diabetes globally, which is predicted to reach 700 million by 2045.

Furthermore, several public-private organizations are undertaking initiatives to facilitate kidney disease testing in key regions. For instance, in July 2020, the National Kidney Foundation (NKF) in collaboration with the National Committee for Quality Assurance (NCQA), introduced a new kidney health evaluation measure, specifically for patients with diabetes. The new guidelines suggest routinely test of diabetes patients for kidney diseases. Such initiatives are anticipated to create a lucrative environment for market growth.

 

Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.

  • Drug Testing Market - The global drug testing market size to be valued at USD 11.7 billion by 2028 and is expected to grow at a compound annual growth rate (CAGR) of 4.9% during the forecast period. Stringent regulations by government agencies mandating alcohol and drug testing for safety purposes and increasing initiatives to monitor and combat substance abuse are anticipated to support the market growth.

 

  • qPCR Instruments Market - The global qPCR instruments market size to be valued at USD 1.39 billion by 2028 and is expected to grow at a compound annual growth rate (CAGR) of 3.4% during the forecast period. The growing prevalence of diseases, technological advancements, and increasing demand for qPCR instruments are anticipated to drive the market over the forecast period. Increased focus on diagnostics attributed to the spread of COVID-19 is projected to propel the demand for qPCR instruments in the upcoming years.

 

Kidney Function Tests Market Segmentation

Grand View Research has segmented the global kidney function tests market on the basis of product, end-use, and region:

Kidney Function Tests Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Clearance Tests
  • Urine Tests
  • Blood Tests
  • Dilution and Concentration Tests
  • Other Tests

 

Kidney Function Tests End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals
  • Diagnostic Laboratories
  • Research Laboratories and Institutes
  • Others

 

Regional Outlook (Volume, Million Units; Revenue, USD Million, 2016 - 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Market Share Insights

  • September 2020: Baxter International, Inc. went under a strategic alliance with bioMérieux for the distribution of NEPHROCLEARTM CCL14 tests. Currently, under development, the NEPHROCLEARTM CCL14 test is designed to assess the chance of persistent severe AKI. 

 

Key Companies profiled:

Some prominent players in the global Kidney Function Tests market include

  • Abbott Laboratories
  • Danaher Corporation (Beckman Coulter, Inc.)
  • Hoffmann-La Roche
  • Sysmex Corporation
  • Siemens Healthineers
  • Randox Laboratories
  • Quest Diagnostics
  • Acon Laboratories
  • Nova Biomedical
  • Laboratory Corporation of America Holdings (LabCorp)

 

Order a free sample PDF of the Kidney Function Tests Market Intelligence Study, published by Grand View Research.

 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

 

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments

Post a Comment

Popular posts from this blog

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p...
Read more

All Countries Dialyzer Industry 2013-2028 - Market Size, Share, Outlook, Growth, Key Players and Forecast

The global Dialyzer market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Dialyzer from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dialyzer market. Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-dialyzer-market/request-sample Leading players of Dialyzer including: • Fresenius Medical Care • Baxter • Nipro • Asahi Kasei • Toray • B.Braun • Nikkiso • Medtronic • Kawasumi • Medica • Wego • Lengthen • Peony Medical • Chengdu OCI • Bain Medical Equipment Market split by Type, can be divided into: • Flat Type Dialyzer • Coil Tube Dialyzer • Ho...
Read more

Insights into the Medical Waste Disposal Category: A Comprehensive Procurement Intelligence Report

  Medical Waste Disposal Category Overview The medical waste disposal category is anticipated to grow at a CAGR of 6.0% from 2023 to 2030. Appropriate disposal of medical trash is the key challenge for healthcare providers across the globe. Rising awareness about the benefits of proper medical waste management for treatment, recycling, and disposal of medical trash has boosted the growth of the category. According to the World Health Organization Study Report 2022, countries with low income generate over 0.2 kg of medical trash per day per hospital bed, whereas countries with high income generate hazardous waste of up to 0.5 kg per hospital bed each day. Moreover, rising government initiatives and strict rules and regulations for waste management are also expected to drive the category. For instance, in December 2022, an MOU was signed between the Center for Health Environment Research and Development and Can Tho Central General Hospital under USAID’s Reducing Pollution Project. T...
Read more